Effect of Modified Playground Environment on Health, Particularly Immune System (ImmunoG1)
Primary Purpose
Atopic Disorders, Immune System Diseases
Status
Completed
Phase
Not Applicable
Locations
Finland
Study Type
Interventional
Intervention
Biodiversity powder
Placebo
Sponsored by
About this trial
This is an interventional basic science trial for Atopic Disorders focused on measuring biodiversity intervention, sand box, guidance
Eligibility Criteria
Inclusion Criteria:
- healthy
- born in Finland
- spends daily (5 d a week) several hours in one of the daycares in which the trial was performed
Exclusion Criteria:
- medication affecting immune system function
- medication affecting microbiota
- cancer
- immune deficiency
- living on a farm
- not born in Finland
Sites / Locations
- Helsinki University
Arms of the Study
Arm 1
Arm 2
Arm Type
Experimental
Placebo Comparator
Arm Label
Intervention
Placebo
Arm Description
The children were in daily contact with biodiversity sand 5 days a week for two weeks.
Children were in contact with normal but colored sand that looked as it were the biodiversity sand. All the other details were as above.
Outcomes
Primary Outcome Measures
Change in Interleukin 10 level in blood
The difference between day 0 and a follow up day in intervention
Secondary Outcome Measures
changes in microbiota
all potential changes in bacterial profile are measured on skin and stool samples
changes in interleukin 17 levels
all measured changes in interleukin 17 levels
changes in tgf-beta levels
change in tgf-beta levels
ratio il-10 / il-17
potential changes in the ratio of these two citokines
long-term changes in microbiota
potential changes that last for four weeks
Full Information
NCT ID
NCT03997175
First Posted
June 23, 2019
Last Updated
June 23, 2019
Sponsor
University of Helsinki
Collaborators
Tampere University
1. Study Identification
Unique Protocol Identification Number
NCT03997175
Brief Title
Effect of Modified Playground Environment on Health, Particularly Immune System
Acronym
ImmunoG1
Official Title
ImmunoGarden - Effect of Modified Playground Environment on Health, Particularly Immune System
Study Type
Interventional
2. Study Status
Record Verification Date
June 2019
Overall Recruitment Status
Completed
Study Start Date
April 15, 2018 (Actual)
Primary Completion Date
July 30, 2018 (Actual)
Study Completion Date
July 30, 2018 (Actual)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
University of Helsinki
Collaborators
Tampere University
4. Oversight
Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No
5. Study Description
Brief Summary
Children were exposed to biodiverse material or non-diverse material in sand pits. The two arms were compared. Immune response and bacterial markers were followed.
Detailed Description
Children of age 3-5 were randomly divided into two groups (arms). One received guidance and biodiverse material for 20 minutes each day for two weeks. The other received the a similar material and guidance but the microbial community in the material was poor in diversity. Bacterial community changes and immune system markers were analyzed and compared between the two arms. Potential changes in Interleukin 10 was the primary outcome.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Atopic Disorders, Immune System Diseases
Keywords
biodiversity intervention, sand box, guidance
7. Study Design
Primary Purpose
Basic Science
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Model Description
One arm received biodiversity sand and the other arm normal sand.
Masking
ParticipantCare ProviderInvestigatorOutcomes Assessor
Masking Description
Participants nor their parents did not know the arm. Care providers did not know the group as they did not know the content of the sand box. Investigators and field assistants knew the content in each sand box but they did not know the coding of the arms when they analyzed the differences in cytokine levels. Outcomes assessors i.e. nurses who took blood samples did not know the arms nor the contents of the sand boxes.
Allocation
Randomized
Enrollment
25 (Actual)
8. Arms, Groups, and Interventions
Arm Title
Intervention
Arm Type
Experimental
Arm Description
The children were in daily contact with biodiversity sand 5 days a week for two weeks.
Arm Title
Placebo
Arm Type
Placebo Comparator
Arm Description
Children were in contact with normal but colored sand that looked as it were the biodiversity sand. All the other details were as above.
Intervention Type
Other
Intervention Name(s)
Biodiversity powder
Other Intervention Name(s)
Biodiversity sand, Biodiversity intervention
Intervention Description
Biodiversity sand contained biodiversity powder that contains a highly diverse and rich microbial community but no known pathogens.
Intervention Type
Other
Intervention Name(s)
Placebo
Other Intervention Name(s)
Placebo sand
Intervention Description
Sand that looks like intervention sand but does not have high biodiversity
Primary Outcome Measure Information:
Title
Change in Interleukin 10 level in blood
Description
The difference between day 0 and a follow up day in intervention
Time Frame
two weeks
Secondary Outcome Measure Information:
Title
changes in microbiota
Description
all potential changes in bacterial profile are measured on skin and stool samples
Time Frame
two weeks
Title
changes in interleukin 17 levels
Description
all measured changes in interleukin 17 levels
Time Frame
two weeks
Title
changes in tgf-beta levels
Description
change in tgf-beta levels
Time Frame
two weeks
Title
ratio il-10 / il-17
Description
potential changes in the ratio of these two citokines
Time Frame
two weeks
Title
long-term changes in microbiota
Description
potential changes that last for four weeks
Time Frame
four weeks
10. Eligibility
Sex
All
Minimum Age & Unit of Time
3 Years
Maximum Age & Unit of Time
5 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria:
healthy
born in Finland
spends daily (5 d a week) several hours in one of the daycares in which the trial was performed
Exclusion Criteria:
medication affecting immune system function
medication affecting microbiota
cancer
immune deficiency
living on a farm
not born in Finland
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Aki Sinkkonen, ph d
Organizational Affiliation
University of Helsinki
Official's Role
Principal Investigator
Facility Information:
Facility Name
Helsinki University
City
Lahti
State/Province
Häme
ZIP/Postal Code
15140
Country
Finland
12. IPD Sharing Statement
Plan to Share IPD
Undecided
IPD Sharing Plan Description
The local ethical committee and the law in Finland retricts the sharing of information that could lead to distinguishing a study participant. Microbial information is considered to faciliation the identification of study participants. Microbial information will be partly shared to public databases (sequences).
Learn more about this trial
Effect of Modified Playground Environment on Health, Particularly Immune System
We'll reach out to this number within 24 hrs